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Aryl acid specificity of the amide bond synthetase McbA 
suggests broad potential for the biocatalytic synthesis of amides 
 
Mark Petchey,[a] Anibal Cuetos,[a] Benjamin Rowlinson,[a] Stephanie Dannevald,[a] Amina Frese,[a] Peter W. Sutton,[b] Sarah 
Lovelock,[b]ÁRichard C. Lloyd,[b] Ian J.S. Fairlamb[a]* and Gideon Grogan[a]* 
Abstract: Amide bond formation is one of the most important 
reactions in pharmaceutical synthetic chemistry. The 
development of sustainable methods of amide bond formation, 
including those that are catalyzed by enzymes, is therefore of 
significant interest.  The ATP-dependent amide bond synthetase 
(ABS) enzyme McbA, from Marinactinospora thermotolerans, 
catalyzes the formation of amides as part of the biosynthetic 
pathway towards the marinacarboline secondary metabolites.  
The reaction proceeds via an adenylate intermediate, with both 
adenylation and amidation steps catalyzed within one active site.  
In this study, McbA has been applied to the synthesis of 
pharmaceutical-type amides from a range of aryl carboxylic 
acids with partner amines provided at 1-5 molar equivalents.  
The structure of McbA has revealed the structural determinants 
of aryl acid substrate tolerance and differences in conformation 
associated with the two half-reactions catalyzed.  The catalytic 
performance of McbA, coupled with the structure, suggest that 
this and other ABS enzymes may be engineered for applications 
in the sustainable synthesis of pharmaceutically relevant (chiral) 
amides. 
The formation of the amide bond is one of the most important 
reactions in pharmaceutical synthetic chemistry, accounting for 
up to 16% of all synthetic steps in medicinal chemistry 
laboratories.1 Amide bond synthesis typically involves the 
activation of the carboxylic acid, using either toxic chlorinating 
agents, or atom-inefficient coupling reagents,2 and so there is an 
urgent need to investigate methods of amide bond formation that 
are sustainable in terms of reagent safety and atom efficiency.  
Enzymatic methods of amide bond synthesis that display these 
advantages are appealing therefore.3,4 The amide bond is  
encountered in secondary metabolites that are synthesised by 
non-ribosomal peptide synthases (NRPSs).5 In this case, the 
formation of the amide is complex, requiring ATP-dependent 
formation of an intermediate adenylate of the carboxylic acid 
substrate, followed by transfer to a phosphopantetheine thiol 
enabled by an acyl/peptidyl carrier protein (ACP or PCP), 
followed by condensation with the amine substrate, each 
process taking place in a separate domain of a large, multi-
domain NRPS enzyme.  While NRPS-mediated amide bond 
formation may have a role in synthetic biology pathways towards 
amides,6 their structural and catalytic complexity militates 
against their application in preparative in vitro biocatalysis.  
Hydrolases, such as N-acylases7 and lipases,8 have been 
employed for amide bond formation, and are attractive in terms 
of their simplicity and efficiency, but often require ester 
substrates, and suffer from poor substrate scope.  More 
recently, Flitsch and co-workers have recruited the adenylate-
forming ability of a carboxylate reductase (CAR) adenylation-
domain-plus-peptidyl carrier protein (CAR-A-PCP) to the 
formation of amides, although a 100-fold excess of amine was 
required to drive reactions to high conversions.9   
ATP-dependent amide bond synthetases (ABSs) have 
been discovered in secondary metabolite pathways leading to 
compounds such as novobiocin,10 cloromycin11 and 
coumermycin.12  The enzymes NovL and CouL, for example, 
couple the aminoflavone 1 with carboxylic acids 2 and 4 in their 
respective biosynthetic pathways to give amide products 3 and 5 
(Scheme 1A).  
  
Scheme 1. A: Amide bond synthesis by ATP-dependent amide bond 
synthetases (ABSs) NovL and CouL involved in secondary metabolism in 
actinomycetes; B: Formation of marinacarbolines such as 6a from E-carboline 
acid 6 and amine a catalyzed by McbA from Marinactinospora thermotolerans. 
These enzymes are apparently capable of catalyzing 
formation of the adenylate, but also of binding the amine for the 
coupling reaction within the same active site, with no 
involvement of separate acyl carrier protein or condensation 
domains.  A further enzyme, McbA, has recently been reported 
in the biosynthetic pathway towards the marinacarbolines in 
Marinactinospora thermotolerans by Ji and co-workers.13,14 
McbA catalyzes the ATP-dependent coupling of the E-carboline 
derivative 6 with 2-phenylethylamine a to form 6a via adenylate 
7 (Scheme 1B), but, unlike other ABSs, McbA also accepted 
other amines, including substituted 2-phenylethylamines and 
tryptamines, indicating some promise for the application of this 
enzyme to reactions with a wider substrate spectrum.14  These 
studies prompted us to further examine the activity of McbA to 
include a range of E-carboline, and other aryl carboxylic acid 
acceptors.  We have also determined the structure of McbA in 
complex with AMP and 6, which has revealed the substrate 
binding interactions within the active site, and may serve as a 
platform for protein engineering to expand the substrate 
specificity of this and related ABS enzymes. 
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McbA was expressed from a synthetic gene and the 
protein purified using IMAC followed by gel filtration (Figure S1, 
S2).  A sample of the pure enzyme (1 mg mL-1; 9.4 nmol) was 
applied to the coupling of 0.4 mM acid 6 and 0.6 mM  2-
phenylethylamine a, in the presence of 2 mM ATP on an 
analytical scale, and full conversion to product amide 6a was 
observed within 1 h using HPLC. Standard amide product was 
prepared by reaction of the E-carboline ester with the amine in 
DMSO at 90°C (Supporting Information).  We then further 
explored the constraints on substrate structure in the McbA-
catalyzed reaction, but, in contrast to previous work,14 we 
focused on the structure of the carboxylic acid acceptor 
(Scheme 2).  
 
Scheme 2. E-carboline carboxylic acid and amine partners for McbA-catalyzed 
amide bond formations.  
 
Carboxylic acid substrates 6 and 8-11 were synthesized using 
Pictet-Spengler condensations of tryptophan-derived esters with 
relevant aldehydes, followed by hydrolysis of the ester products, 
as detailed in the Supporting Information.  Substitution of the 
acyl group in position 1 of the pyridine ring with a secondary 
hydroxymethyl (8) reduced the conversion to 21% of product 8a 
after 1 h, but 96% conversion was achieved after 24 h. An 
increase in the size of the substituent to benzoyl 9 gave 
conversions to product 9a of 8% and 82% after 1 h and 24 h 
respectively.  Replacement by an ethyl group 10 showed that an 
oxygen atom on this substituent was not necessary, with 100% 
conversion to product 10a again achieved after 24 h.  Even 
replacement with H (11) resulted in 6% conversion to 11a after 
24 h.  The activity of the enzyme was then tested using 
carboxylic acids 6 and 8-11 with amines a-d (Scheme 2, Table 
1).   
 
 
 
 
Table 1. ATP-dependent amide couplings by McbA.  Values represent % 
conversions to amide products after 24 h as determined by HPLC analysis 
 Amine 
Acid a b c d 
6 100 81 6 26 
8 96 100 0 17 
9 82 0 0 0 
10 100 91 0 0 
11 6 0 0 0 
 
McbA catalysed the formation of 6a and 6b with 100% and 81% 
conversion respectively, confirming the findings of Ji and co-
workers.14 However, McbA also catalysed the coupling of 6 to 
the racemic chiral amines c and d to form 6c and 6d, although 
with lower conversions of 6% and 26%. Interestingly, analysis of 
the product 6d by chiral HPLC revealed it to be predominantly of 
the (S)-configuration, and with an e.e. of 96% (Figure S3), 
indicating that McbA is capable of performing kinetic resolution 
reactions. Tryptamine b was also coupled to 10 to give 10b in 
91% yield.  1-Phenylethylamine c proved to be a poor donor 
overall, but 3-phenyl-1-methylpropylamine d was coupled with 8 
to form amide 8d with a conversion of 17%.  Some of the E-
carboline amides synthesized here have been shown to have 
biological activity, most notably against benzodiazepine 
receptors, first reported in the 1980s,15 and are of interest as 
treatments against, for example, alcohol abuse.16 
In order to investigate the broader applicability of McbA to 
amide bond synthesis, aryl acid substrates 12-19, with 
structures more diverged from the E-carboline acid platform, 
were then tested with 2-phenylethylamine a, in an effort to 
produce amide products 12a to 19a (Table 2).  
 
Table 2. ATP-dependent coupling of 12-19 with amine a by McbA. Values 
represent % conversions to amide products after 24 h as determined by HPLC 
analysis. 
Acid Product Conversion (%) 
12 12a 34 
13 13a 23  
14 14a 43  
15 15a 40  
16 16a 41  
17 17a 39  
18 18a 4  
19 19a 24  
 
Overall McbA displayed a surprisingly broad substrate 
range, including substrates such as naphthoic acid 14, indole 
carboxylic acids 15 and 16 and benzofuran-5-carboxylic acid 17, 
although quinoline substrate 18 was transformed with low 
conversion.  Strikingly, McbA, was also able to couple benzoic 
acid 19 with a with a modest but significant conversion of 24%.  
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To investigate the promiscuity in aryl acid recognition by 
McbA, the structure of the enzyme was determined using X-ray 
crystallography. A combination of a K483A mutant, co-
crystallised with AMP, magnesium ions and the E-carboline acid 
substrate 6, yielded crystals of diffraction quality.  The structure 
was solved using molecular replacement, and refined to a 
resolution of 2.80 Å (Data collection and refinement statistics 
can be found in the Supporting Information, Table S2).  McbA 
adopts a structure within the ANL superfamily of adenylating 
enzymes defined by Gulick,17 and which includes firefly 
luciferase,18 acetyl-CoA synthase,19 and standalone adenylation 
domains of NRPSs, including the dihydroxybenzoate 
adenylating enzyme enzyme DhbE20 from the bacillibactin 
biosynthetic pathway.  Each ANL enzyme is characterised by a 
two-domain structure in which a large N-terminal domain is 
coupled to a smaller C-terminal one, of 4-500 and 100 amino 
acid residues respectively. Crucially, the structures of many ANL 
enzymes have revealed substantial relative domain rotation 
during the reaction coordinate, with one conformation 
µDGHQ\ODWLRQ¶ DVVXPHG IRU DGHQ\ODWH IRUPDWLRn from the 
FDUER[\ODWH VXEVWUDWH DQG $73 DQG D VHFRQG µWKLRODWLRQ¶ LQ
which the C-terminal domain rotates to enable the ligation 
reaction between the phosphopantetheinate thiol and the 
adenylate intermediate. 
The McbA structure features the two predicted domains: the 
large N-terminal domain of residues 1-394 (McbAN) and the 
smaller C-terminal one featuring residues 395-494 (McbAC), with 
the hinge residue at Q394.  The McbA structure is unusual 
however in that, of five molecules within the asymmetric unit, 
four (A-'DUH LQWKH µDGHQ\ODWLRQ¶FRQIRUPDWLRQ)LJXUH1a) and 
RQH ( LV LQ WKH µWKLRODWLRQ¶ VWDWH GHVFULEHG DERYH ZKLFK ZH
KDYH WHUPHG µDPLGDWLRQ¶ )LJXUH 1b) for McbA. The adenylation 
conformer of McbA superimposes well with other ANL enzymes 
crystallized in the same state, including PheA (1AMU, 2.1 Å over 
431 CD atoms),21 DhbE (1MD9, 2.3 Å over 445)20 and the 
UHFHQWO\ GHWHUPLQHG VWUXFWXUH RI WKH UHOHYDQW µ$¶ GRPDLQ IURP
CAR from Nocardia iowenis (NiCAR) in complex with benzoic 
acid and AMP (5MSD, 2.8 Å over 406).22   
The substrate 6 is bound within a hydrophobic pocket 
stacked between the loop between G295 and F301 on one face 
and L202 on the other (Figure 2).  Few specific interactions 
between active site residues and the substrate are made, except 
that the carbonyl oxygen and pyridine nitrogen of 6 interact with 
the backbone N-H and C=O of G295 at distances of 
approximately 3.9 and 3.4 Å respectively. The relative lack of 
specific interactions may help to explain the relaxed specificity of 
McbA for the range of aryl acids used in this study.  The 
exception was quinoline derivative 18, in which the N-atom in 
the 1-position has had an adverse effect on conversion, perhaps 
disrupting the hydrophobic interaction made by the native  ligand 
with F301.  Residue D201, which points away from 6 in the 
active site, is replaced in CARs and DhbE by H300, and is close 
to the benzoic acid carboxylate in the CAR-AMP complex 5MSD.  
This histidine has been implicated in the catalysis of both 
adenylation and thiolation reactions in 4-chlorobenzoyl-CoA 
ligase (4CBL, 3CW8, 3CW9).23,24  
The amidation conformer of McbA superimposes well with 
the thiolation conformer of 4-CBL (3CW9, 2.0 Å over 430 CD 
DWRPVDQGDOVRWKHµ$¶GRPDLQLQWKHVWUXFWXUHRI&$5-A-PCP 
(5MSS, 2.5 Å over 402), the construct used in amide-bond 
forming reactions described previously.9 The structure of 4-CBL 
in the thiolation state, in complex with 4-chlorophenacyl- CoA (4-
CPA-CoA, 3CW9, Figure S3a)23 locates the binding site for the 
thiolation product, and permits a comparison with the equivalent 
region of McbA (Figure S3b) The surfaces of the enzymes show 
that positively charged residues in 4-CBL, such as R87, which 
interact with the phosphates in 4-CPA-CoA, are absent in McbA; 
indeed the entrance to the active site features three residues 
with carboxylate side chains, D463, E221 and E400 which may 
favour interaction with incoming amine substrates.   
The McbA-catalyzed synthesis of selected amides was 
scaled up to utilise 50 mg (0.20 mmol) of aryl acids 6, 10, 14, 16, 
17  and 19 in a 50 mL reaction volume, with 1-5 molar 
equivalents 2-phenylethylamine a and two equivalents of ATP 
(198 mg; 0.40 mmol).  Amide products 6a, 10a, 14a, 17a and
 
 
 
 
Figure 1. Structures of McbA in the adenylation (a) and amidation (b) conformations.  In each case the protein is coloured in green from residues 1-394 
(McbAN) and coral from 395-494 (McbAC).  AMP (yellow) is bound at the domain interface and 6 (blue) within a binding pocket in the N-terminal domain. The 
McbAC domain in b is rotated 149° relative to the larger McbAN domain compared with their orientations in a.  
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Figure 2. Active site of adenylation conformer of McbA showing residues 
involved in the binding of substrate 6 and AMP.  Electron density is the Fo-Fc 
(omit) map at a level of 3V before inclusion of the ligand atoms in refinement.  
Ligand atoms have been added for clarity. Selected interactions are indicated 
by black dashed lines. 
19a were isolated by simple liquid-liquid extraction into ethyl 
acetate, giving isolated yields of between 50% and 85% of the 
amide products without further purification (Table 3). 16a was 
also 
Table 3. ATP-dependent coupling of carboxylic acids with amine a by McbA 
on 50 mg scale (*carried out on 30 mg scale).   
Acid Equivalents of amine  Isolated Yield (%) 
6 2              85  (6a) 
10 2 70 (10a)* 
14 2 50 (14a) 
16 5 15 (16a) 
17 5 51 (17a) 
19 5 21 (19a) 
 
isolated, although only in 15% yield owing to complications in 
extraction of this indole product.   These results compare 
favourably with the application of CAR-A-PCP to preparative 
amide bond formation,9 as 100 equivalents of amine donor were 
required for those reactions, against the low ratios reported 
here.  The difference may reflect of the active participation of 
McbA in amine binding and catalysis of amidation, which was 
not yet established for the CAR-A-PCP reaction.  The results 
offer promise for the application of McbA-type enzymes in 
preparative biocatalyzed reactions, particularly if ATP recycling 
methods, currently a subject of significant interest in 
biocatalysis,[25] were to be employed. 
The efficient biocatalytic formation of amide bonds for the 
preparation of pharmaceutical-type amides, is one of the most 
significant reactions for which biocatalytic alternatives are being 
sought.  The studies presented here suggest that McbA and 
related ABS enzymes may provide starting points for the 
evolution of activity towards a wider range of carboxylic acid and 
amine partners, using the structure of McbA as a basis for 
structure-guided evolution.  
Experimental Section 
Details of target selection, gene cloning and expression, enzyme 
purification and assay, synthesis of substrates and product standards, 
HPLC analyses, biotransformation protocols, crystallisation and data 
collection and refinement can be found within the Supporting Information. 
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